A Case of Elephantiasic Pretibial Myxedema Successfully Treated With Intralesional Triamcinolone Acetate

Deep Hathi; Soumik Goswami; Nilanjan Sengupta; Arjun Baidya; Prashant M Gaikwad; Niladri Das; Silima S Tarenia; Rajul Oswal

doi:10.7759/cureus.29234

A Case of Elephantiasic Pretibial Myxedema Successfully Treated With Intralesional Triamcinolone Acetate

Cureus. 2022 Sep 16;14(9):e29234. doi: 10.7759/cureus.29234. eCollection 2022 Sep.

Authors

Deep Hathi¹, Soumik Goswami¹, Nilanjan Sengupta¹, Arjun Baidya¹, Prashant M Gaikwad², Niladri Das², Silima S Tarenia³, Rajul Oswal⁴

Affiliations

¹ Endocrinology, Nil Ratan Sircar Medical College, Kolkata, IND.
² Endocrinology and Diabetes, Nil Ratan Sircar Medical College, Kolkata, IND.
³ Endocrinology, Diabetes and Metabolism, Nil Ratan Sircar Medical College, Kolkata, IND.
⁴ Radiology, Shri Vinoba Bhave Civil Hospital, Silvassa, IND.

Abstract

Graves' dermopathy is one of the extra-thyroidal manifestations of Graves' disease (GD) and is characterized by the accumulation of glycosaminoglycans in the reticular dermis. In the majority of cases, pretibial myxedema is self-limiting but, in some cases, it can lead to structural and functional damage. Topical steroids with occlusive dressing remain the conventional treatment, but intralesional steroids have shown promising results. We hereby present a case of pretibial myxedema treated successfully with intralesional triamcinolone acetate.

Keywords: glucocorticoids; graves dermopathy; graves disease; pretibial myxedema; triamcinolone acetate.

Publication types

Case Reports